Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia

被引：0

作者：

Mashima, Kiyomi ^{[1
]}

Ikeda, Takashi ^{[1
]}

Kawaguchi, Shin-ichiro ^{[1
]}

Toda, Yumiko ^{[1
]}

Ito, Shoko ^{[1
]}

Ochi, Shin-ichi ^{[1
]}

Nagayama, Takashi ^{[1
]}

Umino, Kento ^{[1
]}

Minakata, Daisuke ^{[1
]}

Nakano, Hirofumi ^{[1
]}

Yamasaki, Ryoko ^{[1
]}

Morita, Kaoru ^{[1
]}

Kawasaki, Yasufumi ^{[1
]}

Sugimoto, Miyuki ^{[1
]}

Ishihara, Yuko ^{[1
]}

Ashizawa, Masahiro ^{[1
]}

Yamamoto, Chihiro ^{[1
]}

Fujiwara, Shin-ichiro ^{[1
]}

Hatano, Kaoru ^{[1
]}

Sato, Kazuya ^{[1
]}

Oh, Iekuni ^{[1
]}

Ohmine, Ken ^{[1
]}

Muroi, Kazuo ^{[1
]}

Kanda, Yoshinobu ^{[1
]}

机构：

[1] Jichi Med Univ, Dept Med, Div Hematol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan

来源：

ANNALS OF HEMATOLOGY | 2019年 / 98卷 / 05期

关键词：

Myelodysplastic syndromes (MDS); Erythroid hyperplasia; Non-erythroid cells (NEC); Acute myeloid leukemia (AML); PROGNOSTIC SCORING SYSTEM; CELLULARITY IMPROVES;

D O I：

10.1007/s00277-018-3560-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

It is controversial whether blast percentage based on all nucleated cells (ANC) or non-erythroid cells (NEC) more accurately reflects the prognosis of patients with myelodysplastic syndromes (MDS). We considered that the impact of blast percentage on survival should be similar in MDS with erythroid hyperplasia (MDS-E) and MDS with no erythroid hyperplasia (MDS-NE), and from this perspective, we retrospectively analyzed 322 patients, including 44 with MDS-E and 278 with MDS-NE. Overall survival was similar between the MDS-E and MDS-NE groups (P = 0.94). In a subgroup of patients with bone marrow (BM) blasts of <5%, no difference in survival was found between MDS-E and MDS-NE by either calculation method. However, in patients with a blast percentage between 5 and 10%, a significant difference in survival was observed only when the blast percentage in MDS-E was calculated from ANC (P < 0.001 by ANC and P = 0.66 by NEC). A similar result was observed when we analyzed the remaining patients with higher blasts together with those with blasts between 5 and 10%. These results suggest that the calculation of the BM blast percentage based on NEC in MDS-E provides a blast percentage value with a clinical impact consistent with that in MDS-NE.

引用

页码：1127 / 1133

页数：7

共 45 条

[41] Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes
Guardiola, P
Runde, V
Bacigalupo, A
Ruutu, T
Locatelli, F
Boogaerts, MA
Pagliuca, A
Cornelissen, JJ
Schouten, HC
Carreras, E
Finke, J
van Biezen, A
Brand, R
Niederwieser, D
Gluckman, E
de Witte, TM
BLOOD, 2002, 99 (12) : 4370 - 4378
[42] The non-peptide thrombopoietin receptor agonist Eltrombopag (SB-497115, Promacta/Revolade) does not stimulate malignant growth of bone marrow cells from patients with acute myeloid leukemia or myelodysplastic syndromes
Will, B.
Luciano, J.
Kawahara, M.
Erickson-Miller, C.
Verma, A.
Aivado, M.
Steidl, U.
LEUKEMIA RESEARCH, 2009, 33 : S46 - S47
[43] Retrospective comparison of allogeneic hematopoietic stem cell transplantation (HSCT) with bone marrow (BM) and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells (PBSCS) in Japanese patients with myelodysplastic syndromes (MDS)
Hamaki, T
Tanimoto, T
Ohno, Y
Nishiwaki, K
Tanaka, J
Kobayashi, T
Takaue, Y
Harada, M
EXPERIMENTAL HEMATOLOGY, 2003, 31 (07) : 112 - 112
[44] Analysis of oligoclonally repopulated NOD/SCID-b2microglobulin null mice reveals a strong megakaryocytic and erythroid differentiation bias of adult human short term repopulating cells from mobilized peripheral blood and bone marrow by comparison to cord blood.
Fischer, MB
Schmidt, M
Klingenberg, S
Vonderstrass, B
Eaves, CJ
von Kalle, C
Glimm, H
BLOOD, 2003, 102 (11) : 943A - 943A
[45] A comparison of five different culture protocols shows that growth of human CD34+peripheral blood stem cells in SCF, IL-3, FLT-3 ligand and EPO results in exponential erythroid expansion and a globin gene expression pattern which is similar to that seen in human bone marrow.
Mabaera, RH
Lowrey, CH
BLOOD, 2005, 106 (11) : 1016A - 1016A

← 1 2 3 4 5 →